Diagnostyka

Diagnostyka EBITDA per Share

The EBITDA per Share of Diagnostyka (DIA.WA) as of Nov 14, 2026 is 11.37 PLN. In the previous year, EBITDA per Share was 14.78 PLN — a change of -23.08% (lower).

EBITDA per Share

11.37PLN

YoY

-23.08%

Last updated:

EBITDA per Share of Diagnostyka is 2025 11.37 PLN. EBITDA per Share of Diagnostyka was 2024 14.78 PLN. It decreases by -23.08% lower compared to the previous year.

The Diagnostyka EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
20.37 PLN
Jan 1, 2022
7.47 PLN
Jan 1, 2023
11.28 PLN
Jan 1, 2024
14.78 PLN
Jan 1, 2025
11.37 PLN
The Diagnostyka EBITDA per Share history
YEAREBITDA per ShareYoY
11.37PLN-23.08%
14.78PLN+31.03%
11.28PLN+51.04%
7.47PLN-63.34%
20.37PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

EBITDA per Share of Diagnostyka is 11.37 PLN in 2025.

EBITDA per Share of Diagnostyka changed from 14.78 PLN to 11.37 PLN, representing a -23.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Diagnostyka

All Key Metrics — Diagnostyka